The Food and Drug Administration (FDA) has approved Narcan nasal spray, the first FDA-approved intranasal naloxone hydrochloride spray.
Naloxone is used to arrest the potentially fatal effects of an opioid overdose, particularly potentially fatal respiratory failure.
Adapt Pharma Inc., licensed the popular Narcan brand name from Endo Pharmaceuticals for the nasal spray product. FDA approval was received in mid November. Narcan brand injectable naloxone hydrochloride has been so widely used, for so many years, that “Narcan” has become something of a synonym for naloxone, like calling all tissues “Kleenex.”
Just a couple of days after the Narcan approval, a competing intranasal naloxone spray was disapproved by the FDA. […]